Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Biogen (BIIB) PT Lowered to $337 at RBC Capital
January 30, 2019 6:25 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $337.00 (from $342.00) while maintaining a Sector Perform rating.
... MoreBiogen (BIIB) PT Raised to $380 at Oppenheimer
January 29, 2019 5:29 PM ESTOppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $380.00 (from $372.00) while maintaining a Outperform rating.
Olson noted an 'impressive' Q4 performance which featured a business update that perplexed investors with plans for an intriguing Alzheimer's prevention study.
... More